View this email in your browser.
APR
17
THIS WEEK
  ARTICLE
  Machine Learning is Disrupting Life Science Research - For Good
  ARTICLE
  Nanotechnology: A New Avenue to Fight Cancer
  PRODUCT ANNOUNCEMENT
  Enhance Workflow Efficiency With Rapid Tube Identification
  NEWS
  Weakening Communication in the Brain to Reduce Fear
  NEWS
  Rebiotix Announces Positive Top Line Data from Phase 2 C. Diff Trial

Join Us at Laboratory Design Conference 2017

LDC 2017 provides an unmatched environment to meet peers and explore new developments in the world of laboratory design. Opportunities to tour two prestigious laboratories are also available.

REGISTER TODAY
 
FEATURED STORY

New Therapy Shows Promise in Treating Two Degenerative Brain Diseases

Featured Story

In two parallel collaborative mouse studies, reported April 12 in Nature, researchers found that a DNA-like drug could offer a new therapeutic approach for treating two devastating brain disorders: amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia type 2 (SCA2).


Share Facebook Twitter Google+ LinkedIn StumbleUpon

FULL STORY
 
 

Facilitating Discrimination Between Induction of DNA Damage, Oxidative Stress and Protein Misfolding Using a Novel Multicell GFP Reporter Assay

MilliporeSigma

Utilizing benchtop flow cytometry, new novel multicell GFP reporter assay was developed to help facilitate discrimination between induction of DNA damage, oxidative stress and protein misfolding.


LEARN MORE
 
 
ARTICLE

Machine Learning is Disrupting Life Science Research - For Good

Thumbnail

While it's true that artificial intelligence and computer-based algorithms are making their way into both the lab and clinical practice, the adoption of these new technologies will not replace the work of the researchers themselves. On the contrary: it'll enable them to become more effective than ever before.


FULL STORY
 
 
ARTICLE

Nanotechnology: A New Avenue to Fight Cancer

Thumbnail

Paris-based Nanobiotix is a late clinical-stage nanomedicine company that is spearheading efforts to harness physics rather than biology, as a way to destroy cancer cells.


FULL STORY
 
 

Sample Preparation for the Detection of Synthetic Analogues of Insulin in Human Serum

Genevac LTD

Due to an increase in the abuse of synthetic insulins, doping laboratories require faster and more consistent testing options. The methodology to detect and confirm the presence of peptide hormones by mass spectrometry is preferred to the current use of immunoassays or other immuno-reactive techniques. This white paper explores and compares the different available methods, revealing the fastest and most accurate options for synthetic insulin detection.


DOWNLOAD NOW
 
 
FOCUS ON:

Enhance Workflow Efficiency With Rapid Tube Identification

Thumbnail

Tecan is helping to reduce waiting times for bulk sample identification with an innovative high speed barcode scanner for its Fluent Laboratory Automation Solution. The new Fluent ID* module eliminates the need to watch and wait while your liquid handling platform scans and identifies each individual sample tube, allowing 32 barcoded samples to be loaded and identified in just three seconds.


FULL STORY
 
 
NEWS

Weakening Communication in the Brain to Reduce Fear

Thumbnail

Researchers have used optogenetics to weaken the connection between the amygdala and the cortex in the brains of mice to reverse fearful behavior, which might have implications for the future treatment of post-traumatic stress disorder (PTSD).


FULL STORY
 
 

Limitations and Requirements for Measuring Metabolic Rates: A Mini Review

Sable Systems International

Metabolic measurement of humans and animal models is an important aspect of biomedicine. However, the limitations of current methods in metabolic measurement are not widely understood. This mini-review explains the methodological trade-offs involved in metabolic measurement with flow-through respirometry and specifically addresses limitations regarding temporal resolution and accuracy of metabolic measurement systems with practical solutions.


LEARN MORE
 
 
NEWS

Rebiotix Announces Positive Top Line Data from Phase 2 C. Diff Trial

Thumbnail

Clinical-stage microbiome company, Rebiotix Inc., announced positive top line results from it's prospective, multicenter, open-label, controlled Phase 2 study for the prevention of recurrent Clostridium difficile (C. diff).


FULL STORY
 
 
NEWS

Graphic Characters Known as 'Greebles' Key to Alzheimer's Early Detection

Thumbnail

Researchers are using unique graphic characters as the latest tool to help doctors detect signs of Alzheimer's disease significantly earlier than when the symptoms become apparent.


FULL STORY
 
 
NEWS

Oxytocin Being Tested for Treatment of PTSD and Alcohol Abuse

Thumbnail

A new trial may hold new hope for military personnel through treatment with oxytocin, sometimes referred to as the "love hormone."


FULL STORY
 
 
NEWS

Overcoming Opioids: The Quest for Less Addictive Drugs

Thumbnail

Tummy tucks really hurt. Doctors carve from hip to hip, slicing off skin, tightening muscles, tugging at innards. Patients often need strong painkillers for days or even weeks, but Mary Hernandez went home on just over-the-counter ibuprofen.


FULL STORY
 
Bioscience Technology
Facebook Twitter
SUBSCRIBE | ABOUT US | ADVERTISE
We respect your right to privacy - view our policy here.
This mailbox is unattended, so please do not reply to this message. Contact us for assistance.
If you no longer wish to receive these emails - unsubscribe here.
This email was sent by: Bioscience Technology
100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129
© 2017 Bioscience Technology. All rights reserved.